Skip to content

Clinical trials

Observational Brain Diseases trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Brain Diseases Phase: Observational Country / region: Canada Clear all

5 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20151
20161
20171
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed2
Enrolling by invitation1
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
BlueRock Therapeutics1
Columbia University1
Shire1
Sumitomo Pharma Switzerland GmbH1
University of Saskatchewan1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Brain Diseases5
Central Nervous System Diseases4
Nervous System Diseases3
Brain Diseases, Metabolic, Inborn2
Genetic Diseases, Inborn2
Lipid Metabolism Disorders2
Lysosomal Storage Diseases2
Metabolic Diseases2
Metabolism, Inborn Errors2
Sphingolipidoses2

Trials

Showing 1 to 5 of 5. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.